Dissemin is shutting down on January 1st, 2025

Published in

BMJ Publishing Group, Gut, 4(28), p. 410-415, 1987

DOI: 10.1136/gut.28.4.410

Elsevier Masson, Joint Bone Spine, 5(72), p. 354-356

DOI: 10.1016/j.jbspin.2004.12.002

Portland Press, Clinical Science, s13(70), p. 37P.3-37P

DOI: 10.1042/cs070037pb

Links

Tools

Export citation

Search in Google Scholar

Osteoporosis in patients with inflammatory bowel disease

Journal article published in 1986 by J. E. Compston, Nathalie Demerjian-Somogyi, D. Judd, Elisabeth Palazzo, E. O. Crawley, W. D. Evans, C. Cooper, C. Evans, H. A. Church, Charles N. Bernstein, E. M. Reid, Martine Cohen-Solal ORCID, J. Rhodes, Nk K. Arden
This paper is available in a repository.
This paper is available in a repository.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Green circle
Postprint: archiving allowed
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Bone mineral content in spinal trabecular and peripheral cortical bone was measured in 75 unselected patients with small and/or large intestinal inflammatory bowel disease. Osteoporosis, defined as a bone mineral content greater than 2 SD below the age and sex matched normal mean value was present in 23 patients (30.6%). Three amenorrhoeic females aged 34, 38, and 42 years had severe clinical osteoporosis and a further three patients had one or more vertebral crush fractures. Eighteen of the 23 patients with osteoporosis had small intestinal disease with one or more resections and the mean lifetime steroid dose in those with osteoporosis was significantly higher than in those with normal bone mineral content. Bone mineral content in spinal trabecular bone showed significant negative correlations with lifetime steroid dose and serum alkaline phosphatase and a significant positive correlation with serum albumin. Peripheral cortical bone mineral content was positively correlated with body weight, height and body mass index. We conclude that the prevalence of osteoporosis is increased in patients with inflammatory bowel disease, severe clinical osteoporosis developing in some relatively young patients. The pathogenesis of this bone loss is probably multifactorial; steroid therapy is likely to be an important contributory factor.